Navigation Links
Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
Date:9/13/2010

ign safety profile in line with our oral presentation at ASCO. As of August 31, 2010 we have completed enrollment of an additional cohort of 10 patients using a fixed, continuous dosing of 560 mg daily. Additionally, the National Cancer Institute (NCI) has dosed the first of 10 pre-typed ABC DLBCL patients. The company has submitted an abstract to the 2010 ASH annual meeting that describes the responses and the duration in all of the CLL/SLL patients dosed to date and we cannot disclose any information contained in the abstract prior to the meeting held in December.
  • Over the last 3 months the company held multiple advisory boards in the US and EU with experts in the field of lymphoma and CLL to obtain feedback to our clinical development plan. We now announce that the company is planning multiple Phase II trials in select B-cell derived malignancies (Mantle Cell in Velcade failure and Velcade naive patients, DLBCL in R-CHOP and transplant failures and CLL combination-safety trials with Bendamustine-Rituxan and Ofatumumab and other investigator initiated trials). Timelines for reportable events and regulatory interactions from these planned Phase II trials will be communicated after the ASH meeting in December.
  • A second Bruton's Tyrosine Kinase (Btk) Inhibitor, PCI-45292, is being developed for autoimmune disease; we are on track to complete IND-enabling preclinical safety studies. The company is planning to file an IND by the end of the second quarter of calendar 2011 with this molecule.
  • Factor VIIa Inhibitor, PCI-27483, is a potent and highly selective small molecule inhibitor of coagulation Factor VIIa.  Factor VIIa is best known for its role in triggering the extrinsic pathway of blood coagulation following contact and complex formation with the cell surface glycoprotein Tissue Factor.  Tissue Factor is over-expressed in pancreatic, gastric, lung, breast, colon and many other cancers of epithelial origin. FVIIa In
    '/>"/>

  • SOURCE Pharmacyclics
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
    2. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
    3. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
    4. Pharmacyclics Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
    5. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
    6. Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
    7. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
    8. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
    9. Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
    10. Pharmacyclics to Present at Merriman Curhan Fords Investor Summit 2009
    11. Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... , Sept. 19, 2014 Harwood Feffer LLP ... board of directors of PDL BioPharma, Inc. ("PDL" or ... the board has breached its fiduciary duties to shareholders ... September 16, 2014, the Company disclosed: "On September 11, ... accounting firm, Ernst & Young LLP ("EY"), that it ...
    (Date:9/19/2014)... 19, 2014 "Copay coupons," a ... of brand drugs among patients with prescription drug coverage, may ... a new report  from the Department of ... General (OIG). Federal anti-kickback laws prohibit suppliers from ... subsidized by the federal government. ...
    (Date:9/19/2014)... Sept. 19, 2014 Today, iHealth Lab Inc. announced ... Ventures, Ltd. for its first institutional round of funding. ... iHealth,s global reach, accelerate growth and innovation, and invest ... the investment, Xiaomi Ventures will join iHealth,s board of ... infrastructure and ecommerce. "We are very pleased ...
    Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D 2iHealth Raises $25 Million to Fuel Growth and Global Market Share 2
    ... , , GREENSBORO, N.C., Dec. 23 ... four users who allege kidney damage due to the use ... in preparation for a colonoscopy. (Holshouser et al v. ... are against two Morrisville, N.C., pharmaceutical companies, Salix Pharmaceuticals, Ltd., ...
    ... , , Accelerated approval ... Dec. 23 The U.S. Food and Drug Administration today ... ages 65 years and older to prevent disease caused by ... http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , People in this age group ...
    Cached Medicine Technology:Suits Commenced Against Maker of Prescription Cleansing Drug 2FDA Approves a High Dose Seasonal Influenza Vaccine Specifically Intended for People Ages 65 and Older 2FDA Approves a High Dose Seasonal Influenza Vaccine Specifically Intended for People Ages 65 and Older 3
    (Date:9/21/2014)... September 21, 2014 The Electronic ... and supports electronic medical records (EMR) and electronic ... federal healthcare legislation during the past five years ... during the five years to 2019. The 2009 ... Act established Medicare and Medicaid incentives to encourage ...
    (Date:9/21/2014)... Originally approved by the Food ... (fluticasone propionate) is a synthetic ICS therapy with ... maintenance treatment of asthma prophylactically in children and ... Diskus and HFA, which received the FDA approval ... fluticasone propionate, can bind to glucocorticoid receptors with ...
    (Date:9/21/2014)... New York, NY (PRWEB) September 21, 2014 ... ( http://www.thegranuflolawsuit.com/ ) have been added over the ... involving claims that allege serious cardiovascular injuries caused ... , A Case List updated on September 15th ... underway in the U.S. District Court, District of ...
    (Date:9/21/2014)... California (PRWEB) September 21, 2014 Developers ... plugins have announced a new transition plugin entitled ... Vol. 3 delivers high quality transitions that will add ... said Christina Austin, CEO of Pixel Film Studios. “Blurring ... is a definite game changer.” , Transpack Vol. 3 ...
    (Date:9/21/2014)... 2014 Top10BestSEOHosting.com, a leading review ... and GreenGeeks are the most recommended hosting suppliers ... high quality hosting products. , “Don’t waste ... we recommend two great hosting companies to you,” ... that iPage and GreenGeeks are the most recommended ...
    Breaking Medicine News(10 mins):Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 4Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 3Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 4Health News:Pixel Film Studios Released Transpack Vol. 3 Plugin Exclusively for Final Cut Pro X 2Health News:Leading Review Website Top10BestSEOHosting.com Unveils The Best Hosting Suppliers In September 2
    ... are doing their bit to raise awareness about Ovarian Cancer ... is a nice gesture that celebrities are lending their support ... "silent killer" in medical circles. ,"For too long ... research now shows that, even in the early stages, most ...
    ... confirmed that the dreaded bird flu had made an entry into ... cat had died of bird flu. Since then the country has ... Federal Agriculture and Protection of Consumer Minister Horst Seehofer has said ... kept inside homes, while it is compulsory to keep dogs on ...
    ... is a gigantic problem but Childhood obesity rates are soaring ... parts of the world by the end of the decade ... ,As estimated by 2010 the number of overweight and obese ... ,Over a million children will show signs of ...
    ... who wish to have children of their own are growing ... whereby single women in their 30’s and 40’s desirous of ... treatment on the National Health Service.// ,Hospital ... without their partners. Camden primary care trust in London will ...
    ... based Bharat Biotech International, two major pharma companies, agreed ... flu that will cater to the needs of Indian ... agreement, Bharat Biotech will fund all pre-clinical and clinical ... commercialisation of the single dose vaccine. In return, Novavax ...
    ... Researchers say that just leading a healthy lifestyle like ... ,Elizabeth Selvin and other researchers at John ... on erectile dysfunction (ED) from more than 2,200 adult ... participants in the US government's 2001-2002 National Health and ...
    Cached Medicine News:Health News:Pharma Companies Tie Up To Develop Bird Flu Vaccine 2
    ... Powershaver™ S1 is an innovative, extremely ... its standard handpiece, a smaller small joint ... substantially higher speed are available. All handpieces ... can be operated with all existing KARL ...
    ... light source is equipped with a 180 watt Xenon ... collection and energy transfer from the lamp to the ... output, which is equivalent to higher watt bulbs. A ... lower watt bulb reduces the amount of heat generated ...
    ... Documentation System brings intra-operative image management and ... This system combines cutting edge technology, flexibility, ... with the best possible outcome. Linvatec offers ... or moving video clips: CD or DVD, ...
    ... watt halogen light source with ... ,SOLOS Endoscopy shares your commitment ... the highest quality care available ... development of advanced surgical instruments ...
    Medicine Products: